Search Results 401-410 of 10870 for Acute bronchitis
This is a Phase 1b, open-label, non-randomized, multicenter study to evaluate the safety of orally administered ABT-199 combined with decitabine or azacitidine ...
Receipt of non-licensed treatment for influenza within the last 2 weeks (or plans to receive any time during the study). · Symptoms or signs of the acute ...
Breathlessness and exercise intolerance. Bronchiectasis. Bronchitis. Chest infections. Chronic cough. Chronic obstructive pulmonary disease (COPD). Emphysema.
Severe and prolonged coughing attacks may: Provoke vomiting; Result in a red or blue face; Cause extreme fatigue; End with a high-pitched "whoop" sound during ...
... acute ischemic stroke or high risk TIA (1) reduces recurrent stroke, acute coronary syndrome, and all-cause mortality 6 months after the event, and (2) ...
Nebulized Nitroglycerin for Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome: A Case Report. A A Pract. 2021 Feb 5; 15 (2):e01376 ...
Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...
Breathing conditions that can lead to hypoxemia include: ARDS (acute respiratory distress syndrome) — a lack of air due to a buildup of fluid in the lungs ...
This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic leukemia that has come ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.